AstraZeneca has allocated $3.5billion to expand its US manufacturing and research footprint by the end of 2026. The funding ...

Cambridge: AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company ...

MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the ...

The FTSE 100 and European stocks opened lower on Friday morning in London as chancellor Rachel Reeves said she is "not ...

Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his ...